Sara Nayeem
New Enterprise Associates Partner
Your Intro Paths to Sara Nayeem
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Sara Nayeem on
cblocation
Washington, District of Columbia
investment range
$200k - $40.0m
sweet spot
$10.0m
Sara Nayeem's Past Investments (8)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Centrexion | Series D | $67M (Lead) | Jan 2018 | |
| Complexa | Series C | $62M (Lead) | Jul 2017 | |
| Mersana Therapeutics | Series C | $33M | Jun 2016 | |
| TESARO | Post-IPO Equity | $155M (Lead) | Mar 2016 | |
| Mersana Therapeutics | Series B | $35M (Lead) | Mar 2015 | |
| Mersana Therapeutics | Series A | $14.5M | Apr 2014 | |
| TESARO | Series B | $101M | Jun 2011 | |
| TESARO | Series A | $60M (Lead) | May 2010 |
Sara Nayeem's Experience
Partner New Enterprise Associates (NEA)2015 - Present
Principal New Enterprise Associates (NEA)2010 - 2015
Principal New Enterprise Associates2010 - 2015
Senior Associate New Enterprise Associates2009 - 2009
Senior Associate New Enterprise Associates (NEA)2009 - 2009
Investment Banking Associate Merrill Lynch2006 - 2009
Investment Banking Analyst Morgan Stanley1999 - 2001
Sara Nayeem's Education
Yale University MD / MBA
Harvard University AB Biological Sciences
Sara Nayeem's Media
No media found for Sara Nayeem. Add it now.
Your Intro Paths to Sara Nayeem
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Sara Nayeem on
cb